Cargando…
Assessment of Glycometabolism Impairment and Glucose Variability Using Flash Glucose Monitoring System in Patients With Adrenal Diseases
BACKGROUND: This study aimed to investigate the characteristics and extent of glycometabolism impairment in patients with adrenal diseases, including Cushing syndrome, primary aldosteronism, pheochromocytoma, and nonfunctional adrenal incidentaloma. METHODS: This study enrolled thirty-two patients w...
Autores principales: | Han, Minmin, Cao, Xiaoming, Zhao, Changjian, Yang, Luyang, Yin, Nan, Shen, Pengliang, Zhang, Jin, Gao, Fei, Ren, Yi, Liang, Dong, Yang, Jing, Zhang, Yi, Liu, Yunfeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7546367/ https://www.ncbi.nlm.nih.gov/pubmed/33101192 http://dx.doi.org/10.3389/fendo.2020.544752 |
Ejemplares similares
-
Flash glucose monitoring system was applied to cortisol treatment for a patient with congenital adrenal hyperplasia and 17α-hydroxylase deficiency
por: Xiang, Chenyu, et al.
Publicado: (2020) -
Real-Time Flash Glucose Monitoring Had Better Effects on Daily Glycemic Control Compared With Retrospective Flash Glucose Monitoring in Patients With Type 2 Diabetes on Premix Insulin Therapy
por: Yan, Reng-na, et al.
Publicado: (2022) -
Glycometabolic Alterations in Secondary Adrenal Insufficiency: Does Replacement Therapy Play a Role?
por: Graziadio, Chiara, et al.
Publicado: (2018) -
Flash glucose monitoring with the FreeStyle Libre 2 compared with self-monitoring of blood glucose in suboptimally controlled type 1 diabetes: the FLASH-UK randomised controlled trial protocol
por: Wilmot, Emma G, et al.
Publicado: (2021) -
To Assess Liraglutide’s Therapeutic Effect in Patients with Type 2 Diabetes Mellitus Using Flash Glucose Monitoring System
por: Yin, Jianhong, et al.
Publicado: (2021)